NS1‐binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c‐Myc

Abstract

BackgroundCisplatin-based chemotherapy with concurrent radiotherapy is a standard treatment for advanced esophageal squamous cell carcinoma (ESCC). NS1-binding protein (NS1-BP), a member of the BTB-kelch protein family, has been shown to inhibit the proliferation of Hela cells by suppressing c-Myc. In the present study, we examined the potential function role of NS1-BP expression in ESCC, and particularly, the sensitivity of ESCC to radiotherapy.MethodsNS1-BP expression was examined using immunohistochemistry in two cohorts (n = 98 for the training cohort; n = 46 for independent validation cohort) of ESCC patients receiving cisplatin-based chemotherapy and concurrent radiotherapy. Normal esophageal mucosal tissue blocks were used as a control. We also conducted a series of in vitro and in vivo experiments to examine the potential effects of over-expressing NS1-BP on ESCC cells, and particularly their sensitivity to ionizing irradiation.ResultsIn the training cohort, NS1-BP downregulation was observed in 59% (85/144) of the ESCC specimens. NS1-BP downregulation was associated with chemoradiotherapeutic resistance and shorter disease-specific survival (DSS) in both the training and validation cohorts. Over-expressing NS1-BP in cultured ESCC cells substantially increased the cellular response to irradiation both in vitro and in vivo. NS1-BP also significantly enhanced IR-induced apoptosis, and abrogated IR-induced G2/M cell-cycle arrest and ATM/Chk1 phosphorylation. Immunoprecipitation assays indicated that NS1-BP could interact with c-Myc promoter regions to inhibit its transcription. In ESCC tissues, c-Myc expression was inversely correlated with NS1-BP levels, and was associated with a shorter DSS.ConclusionsOur findings highlight the role and importance of NS1-BP in radiosensitivity of ESCC. Targeting the NS1-BP/c-Myc pathway may provide a novel therapeutic strategy for ESCC.

Knockdown of MSI1 inhibits the proliferation of human oral squamous cell carcinoma by inactivating STAT3 signaling

“…In addition, the results of the cell cycle analysis demonstrated that MSI1 suppression induced cell cycle arrest, which is considered to be an important factor in regulating cancer progression. Our findings were in agreement with those of previous studies on other types of tumors (26,27).…”

The immune landscape of esophageal cancer

“…Esophageal cancer (EC) is the eighth most common cancer type and the sixth leading cause of cancer death worldwide [1]. It mainly includes esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) [2].…”

CircDUSP16 promotes the tumorigenesis and invasion of gastric cancer by sponging miR-145-5p

“…miR-145-5p also inhibited cell growth and invasion and attenuated circDUSP16-induced tumor-promoting effects in GC cells. It was shown that NS1-Binding Protein (NS1-BP) is implicated in c-Myc transcriptional control [32] and facilitates the radio-sensitivity by inhibiting c-Myc in esophageal squamous cell carcinoma [33]. We found that influenza virus NS1A-binding protein (IVNS1ABP) was a direct target of miR-145-5p and miR-145-5p reduced circDUSP16-induced IVNS1ABP expression in GC cells.…”